Patrick O'Brien, COO and General Counsel at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 7,500 shares at $37.39 ($280K) on 2023-01-05, disclosed to the SEC on 2023-01-06.
Seasonal sale ($280k) by COO and General Counsel — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| GLRE | SELL | 2025-05-14 | $267K | — | Filing → |
| ARWR | SELL | 2025-01-07 | $1.3M | — | Filing → |
| ARWR | SELL | 2024-01-05 | $1.9M | — | Filing → |